Pasithea Therapeutics KTTA Growth Metrics (2021-2026)

NASDAQ KTTA
$0.47 -0.02 (-4.08%)
At close: Aug 20, 2026 · 4:00 PM EDT
Growth Metrics Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin (QoQ) (Quarter) -0.83M2.39M-0.02M
EBIT Margin (QoQ) (Quarter) -0.83M2.39M-0.02M
EBT Margin (QoQ) (Quarter) -0.80M1.75M-0.00M
Enterprise Value Growth (1y) (Quarter) -21,638.85%-106.16%37.53%40.55%44.16%53.58%50.64%59.85%73.48%52.43%57.61%55.52%12.68%54.88%-698.83%-845.49%
Enterprise Value Growth (3y) (Quarter) -306.21%23.08%49.25%52.65%49.43%53.64%-18.67%-19.07%
Enterprise Value Growth (5y) (Quarter) -195.93%
Enterprise Value (QoQ) (Quarter) -157.55%4.99%4.73%11.56%21.96%9.59%10.51%26.49%17.02%26.46%40.88%-31.85%26.05%22.84%-16.08%31.88%-1,209.34%8.68%
FCF Margin (QoQ) (Quarter) 0.15M1.22M0.08M
Gross Margin (QoQ) (Quarter) -0.00M0.01M0.00M
Interest Coverage Ratio Growth (1y) (Quarter) -15,301.49%-25.78%-3.04%73.57%54.46%3.40%-210.53%-165.02%
Interest Coverage Ratio Growth (3y) (Quarter) 25.87%-14.93%
Interest Coverage Ratio (QoQ) (Quarter) 98.42%-19.18%1.03%2.37%74.61%-107.10%18.39%-2,571.52%94.13%
Net Margin (QoQ) (Quarter) -0.11M0.36M-0.16M
Operating Margin (QoQ) (Quarter) -0.83M2.39M-0.02M
Return on Assets Growth (1y) (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-1.00-1.000.00M0.00M0.00M1.00
Return on Assets Growth (3y) (Quarter) -1.00-1.00-1.00-1.000.00M0.00M
Return on Assets (QoQ) (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed Growth (1y) (Quarter) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-679.00-713.000.00M0.01M
Return on Capital Employed Growth (3y) (Quarter) -0.01M-0.01M-0.01M-0.01M-0.00M-12.00
Return on Capital Employed (QoQ) (Quarter) -2.00-561.00-644.00-916.00-520.00-454.00-593.00-0.00M-0.00M-0.00M-149.00448.00-0.00M331.00-184.000.00M0.00M
Return on Sales (QoQ) (Quarter) -11.0036.00-16.00